Blood pressure drug may shield young cancer patients from crippling bone disease

NCT ID NCT04401267

First seen Jun 25, 2026 · Last updated Jul 21, 2026 · Updated 3 times

Summary

This study tested whether keeping blood pressure in a lower, healthier range could prevent a painful bone condition called osteonecrosis in children and young adults being treated for leukemia. Fifty-one participants were randomly assigned to either intensive or standard blood pressure control. The goal was to see if tighter blood pressure management could reduce bone damage seen on MRI scans.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Intensive Antihypertensive Therapy
What this could lead to
If successful, this could lead to a simple way to prevent painful bone damage in children undergoing leukemia treatment.
What could go wrong
This is a small, early-phase trial (51 participants) and results may not apply to all patients. Intensive blood pressure control also carries its own risks, like dizziness or low blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • St. Jude Affiliate Clinic - Novant Health Hemby Children's Hospital

    Charlotte, North Carolina, 28204, United States

  • St. Jude Children's Research Hospital

    Memphis, Tennessee, 38105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.